Stockreport

Vaccine Adjuvants Market to Hit USD 0.96 Billion by 2029 with 6.5% CAGR | MarketsandMarkets™ [Yahoo! Finance]

Agenus Inc.  (AGEN) 
Last agenus inc. earnings: 3/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: agenusbio.com/investors
PDF a significant CAGR of 6.5%. The growing demand for the increasing prevalence of infectious diseases and the development of next-generation adjuvants, such as saponin-bas [Read more]